Enfusion, Inc (ENFN) Misses Q3 EPS by 3c

Enfusion, Inc (NYSE: ENFN) reported Q3 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $44.36 million versus the consensus estimate of $44.05 million.

For earnings history and earnings-related data on Enfusion, Inc (ENFN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c